BioMarin Pharmaceutical Price Target Maintained With a $80.00/Share by RBC Capital

拜瑪林製藥股價目標保持在80.00美元/分享，由RBC Capital負責維持

道瓊斯 · 10/30 23:30 · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.